266 related articles for article (PubMed ID: 25377785)
1. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.
Ponce DM; Hilden P; Mumaw C; Devlin SM; Lubin M; Giralt S; Goldberg JD; Hanash A; Hsu K; Jenq R; Perales MA; Sauter C; van den Brink MR; Young JW; Brentjens R; Kernan NA; Prockop SE; O'Reilly RJ; Scaradavou A; Paczesny S; Barker JN
Blood; 2015 Jan; 125(1):199-205. PubMed ID: 25377785
[TBL] [Abstract][Full Text] [Related]
2. ST2: the biomarker at the heart of GVHD severity.
Ito S; Barrett AJ
Blood; 2015 Jan; 125(1):10-1. PubMed ID: 25554746
[TBL] [Abstract][Full Text] [Related]
3. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.
Ponce DM; Gonzales A; Lubin M; Castro-Malaspina H; Giralt S; Goldberg JD; Hanash AM; Jakubowski A; Jenq R; Papadopoulos EB; Perales MA; van den Brink MR; Young JW; Boulad F; O'Reilly RJ; Prockop S; Small TN; Scaradavou A; Kernan NA; Stevens CE; Barker JN
Biol Blood Marrow Transplant; 2013 Jun; 19(6):904-11. PubMed ID: 23416854
[TBL] [Abstract][Full Text] [Related]
5. Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.
Holtan SG; Verneris MR; Schultz KR; Newell LF; Meyers G; He F; DeFor TE; Vercellotti GM; Slungaard A; MacMillan ML; Cooley SA; Blazar BR; Panoskaltsis-Mortari A; Weisdorf DJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1029-36. PubMed ID: 25759146
[TBL] [Abstract][Full Text] [Related]
6. Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease.
Patel KJ; Rice RD; Hawke R; Abboud M; Heller G; Scaradavou A; Young JW; Barker JN
Biol Blood Marrow Transplant; 2010 Mar; 16(3):435-40. PubMed ID: 19857590
[TBL] [Abstract][Full Text] [Related]
7. Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide.
Kanakry CG; Bakoyannis G; Perkins SM; McCurdy SR; Vulic A; Warren EH; Daguindau E; Olmsted T; Mumaw C; Towlerton AMH; Cooke KR; O'Donnell PV; Symons HJ; Paczesny S; Luznik L
Haematologica; 2017 May; 102(5):932-940. PubMed ID: 28126963
[TBL] [Abstract][Full Text] [Related]
8. Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups.
Rowan CM; Pike F; Cooke KR; Krance R; Carpenter PA; Duncan C; Jacobsohn DA; Bollard CM; Cruz CRY; Malatpure A; Farag SS; Renbarger J; Liu H; Bakoyannis G; Hanash S; Paczesny S
Blood; 2020 Apr; 135(17):1428-1437. PubMed ID: 31972009
[TBL] [Abstract][Full Text] [Related]
9. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.
Berger M; Albiani R; Sini B; Fagioli F
Transfusion; 2015 Apr; 55(4):736-47. PubMed ID: 25355659
[TBL] [Abstract][Full Text] [Related]
11. ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide.
Solán L; Kwon M; Carbonell D; Dorado N; Balsalobre P; Serrano D; Chicano-Lavilla M; Anguita J; Gayoso J; Díez-Martín JL; Martínez-Laperche C; Buño I
Front Immunol; 2019; 10():2338. PubMed ID: 31649665
[TBL] [Abstract][Full Text] [Related]
12. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
[TBL] [Abstract][Full Text] [Related]
13. One-unit versus two-unit cord-blood transplantation for hematologic cancers.
Wagner JE; Eapen M; Carter S; Wang Y; Schultz KR; Wall DA; Bunin N; Delaney C; Haut P; Margolis D; Peres E; Verneris MR; Walters M; Horowitz MM; Kurtzberg J;
N Engl J Med; 2014 Oct; 371(18):1685-94. PubMed ID: 25354103
[TBL] [Abstract][Full Text] [Related]
14. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.
Vander Lugt MT; Braun TM; Hanash S; Ritz J; Ho VT; Antin JH; Zhang Q; Wong CH; Wang H; Chin A; Gomez A; Harris AC; Levine JE; Choi SW; Couriel D; Reddy P; Ferrara JL; Paczesny S
N Engl J Med; 2013 Aug; 369(6):529-39. PubMed ID: 23924003
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of the Hematopoietic Cell Transplantation Comorbidity Index for Patients Undergoing Reduced-Intensity Conditioning Cord Blood Transplantation.
Salit RB; Oliver DC; Delaney C; Sorror ML; Milano F
Biol Blood Marrow Transplant; 2017 Apr; 23(4):654-658. PubMed ID: 28189904
[TBL] [Abstract][Full Text] [Related]
16. Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years.
El-Jawahri A; Li S; Antin JH; Spitzer TR; Armand PA; Koreth J; Nikiforow S; Ballen KK; Ho VT; Alyea EP; Dey BR; McAfee SL; Glotzbecker BE; Soiffer RJ; Cutler CS; Chen YB
Biol Blood Marrow Transplant; 2016 May; 22(5):910-8. PubMed ID: 26748160
[TBL] [Abstract][Full Text] [Related]
17. Poor survival and prediction of prolonged isolated thrombocytopenia post umbilical cord blood transplantation in patients with hematological malignancies.
Wu Y; Zhang Z; Tu M; Pan T; Ding P; Tang B; Wan X; Yao W; Song K; Sun G; Geng L; Qiang P; Liu H; Zhu X; Sun Z
Hematol Oncol; 2022 Feb; 40(1):82-91. PubMed ID: 34664735
[TBL] [Abstract][Full Text] [Related]
18. Steroid-refractory acute graft-versus-host disease graded III-IV in pediatric patients. A mono-institutional experience with a long-term follow-up.
Berger M; Pessolano R; Carraro F; Saglio F; Vassallo E; Fagioli F
Pediatr Transplant; 2020 Nov; 24(7):e13806. PubMed ID: 32844519
[TBL] [Abstract][Full Text] [Related]
19. Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation.
Harnicar S; Ponce DM; Hilden P; Zheng J; Devlin SM; Lubin M; Pozotrigo M; Mathew S; Adel N; Kernan NA; O'Reilly R; Prockop S; Scaradavou A; Hanash A; Jenq R; van den Brink M; Giralt S; Perales MA; Young JW; Barker JN
Biol Blood Marrow Transplant; 2015 May; 21(5):920-5. PubMed ID: 25687796
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience.
Calore E; Marson P; Pillon M; Tumino M; Tison T; Mainardi C; De Silvestro G; Rossin S; Franceschetto G; Carraro E; Pescarin M; Varotto S; Destro R; Gazzola MV; Basso G; Messina C
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1963-72. PubMed ID: 26183078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
